Clinical Trials Browser

OTHER × Paraproteinemias × 90 days × Clear all

NCT06870760 2026-04-16

Pre-malignant States to Hematologic Malignancies in Firefighters

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Non-Hodgkin, Multiple Myeloma, Paraproteinemias, Neoplasms, Plasma Cell

NCT03236428 2026-03-27

Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma

Phase 2 Active not recruiting

42 enrolled 8 charts

Smoldering Multiple Myeloma, Paraproteinemias

NCT01408225 2026-03-23

B-SCR-MM

Immunoglobulin Light-chain Amyloidosis, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Paraproteinemias

NCT07448779 2026-03-04

GlycAL

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma, Paraproteinemias

NCT05804032 2026-02-18

Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma

Phase 3 Completed

LymphoidPlasma cell

Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Paraproteinemias

NCT05992532 2026-02-11

GammaGA: Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Monoclonal Gammopathies and/or Multiple Myeloma

Gaucher Disease, Multiple Myeloma, Niemann-Pick Diseases, Paraproteinemias, Splenomegaly